Feasibility Study Design

Cross-source consensus on Feasibility Study Design from 1 sources and 5 claims.

1 sources · 5 claims

Uses

The study is an 18-month uncontrolled mixed-methods feasibility study. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
The study period runs from March 2025 to September 2026, with data collection from October 2025 to June 2026. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
Up to nine sites across secondary schools, FE colleges, and community organisations will be recruited. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
The target participant sample is 120–180 young women and girls aged 14–18, plus up to 36 staff members. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
The study welcomes gender-diverse individuals who feel the topic is relevant to them. — Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals